11 – 20 of 95
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency : a phase 3b, open-label, extension study
(
- Contribution to journal › Article
- 2016
-
Mark
Follow-up duration influences the relative importance of OGTT and optimal timing of glucose measurements for predicting future type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients.
(
- Contribution to journal › Article
-
Mark
Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus.
(
- Contribution to journal › Article
-
Mark
GH Safety Workshop Position Paper: a critical appraisal of recombinant human growth hormone therapy in children and adults.
(
- Contribution to journal › Article
-
Mark
Adaptation to acute coronary syndrome-induced stress with lowering of testosterone - a possible survival factor.
(
- Contribution to journal › Article
-
Mark
Endocrine and metabolic diurnal rhythms in young adult men born small vs appropriate for gestational age
(
- Contribution to journal › Article
- 2015
-
Mark
Associations of obesity with socioeconomic and lifestyle factors in middle-aged and elderly men: European Male Aging Study (EMAS).
(
- Contribution to journal › Article
-
Mark
ESE guidelines, why and how.
(
- Contribution to journal › Debate/Note/Editorial